Scientists find way to disrupt brain tumor stem cells

June 11, 2015, Washington University School of Medicine
Neurosurgeon Albert Kim, M.D., Ph.D., shown planning for surgery, leads a team that has identified a new vulnerability in brain tumor stem cells. Such cells are notorious for their ability to resist treatment and regrow tumors. Credit: WUST

Some brain tumors are notoriously difficult to treat. Whether surgically removed, zapped by radiation or infiltrated by chemotherapy drugs, they find a way to return.

The ability of many to regenerate can be traced to stem cells that evade treatment and spur the growth of new tumor cells.

But some brain tumor stem cells may have an Achilles' heel, scientists have found. The ' remarkable abilities have to be maintained, and researchers at Washington University School of Medicine in St. Louis have identified a key player in that maintenance process. When the process is disrupted, they found, so is the spread of cancer.

"This discovery may help us attack the root of some of the deadliest brain tumors," said senior author Albert H. Kim, MD, PhD, assistant professor of neurological surgery. "A successful treatment will very likely require blocking the tumor stem cells' ability to survive and replenish themselves."

The findings are published online June 11 in Cell Reports.

Kim studies glioblastoma, a deadly form of brain cancer that each year strikes about 18,000 people in the United States. The average length of survival after diagnosis is 15 months, and only 30 percent of patients survive more than two years.

Scientists have realized in recent years that some in glioblastomas and other tumors are more resistant to treatment than others. Those same, more defiant cells also are much better at re-establishing cancer after treatment.

Brain tumor stem cells can resist treatment and regrow tumors, but scientists have identified a vulnerability in these cells that could lead to a new approach in battling deadly brain tumors. Credit: Jim Dryden

"These tumor stem cells are really the kingpins of cancers—the cells that direct and drive much of the harm done by tumors," said Kim, who treats patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Kim and his colleagues identified a protein, known as SOX2, that is active in brain tumor stem cells and in healthy stem cells in other parts of the body.

The researchers found that the tumor stem cells' ability to make SOX2 could be turned up or down via another protein, CDC20. Increasing SOX2 by boosting levels of CDC20 also increased a tumor's ability to grow once transplanted into mice. Eliminating CDC20, meanwhile, left tumor stem cells unable to make SOX2, reducing the tumor ' ability to form tumors.

"The rate of growth in some tumors lacking CDC20 dropped by 95 percent compared with tumors with more typical levels of CDC20," Kim said.

When the scientists analyzed human tumor samples, they found that a subset of patients with glioblastomas that had the highest CDC20 levels also had the shortest periods of survival after diagnosis.

Kim's lab is exploring methods to block CDC20 in brain tumors, including RNA interference, an approach in which the production of specific proteins is blocked. That general approach is in clinical trials as a therapy for other cancers, viral infections and other illnesses.

Explore further: Stem cells lurking in tumors can resist treatment

More information: Mao DD, Gujar AD, Mahlokozera T, Chen I, Pan Y, Luo J, Brost T, Thompson EA, Turski A, Leuthardt EC, Dunn GP, Chicoine MR, Rich KM, Dowling JL, Zipfel GJ, Dacey RG, Achilefu S, Tran DD, Yano H, Kim AH. A CDC20-APC/SOX@ signaling axis regulates human glioblastoma stem-like cells. Cell Reports, online June 11, 2015.

Related Stories

Stem cells lurking in tumors can resist treatment

March 12, 2015
Scientists are eager to make use of stem cells' extraordinary power to transform into nearly any kind of cell, but that ability also is cause for concern in cancer treatment. Malignant tumors contain stem cells, prompting ...

Researchers identify protein pathway involved in brain tumor stem cell growth

February 26, 2015
Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification ...

Glioblastoma: Study ties three genes to radiation resistance in recurrent tumors

February 3, 2015
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.

Team discovers novel mechanism controlling lung cancer stem cell growth

April 7, 2015
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists ...

Stem-cell-based therapy promising for treatment of breast cancer metastases in the brain

April 24, 2015
Investigators from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute have developed an imageable mouse model of brain-metastatic breast cancer and shown the potential of a stem-cell-based therapy to ...

Recommended for you

More than 2,500 cancer cases a week could be avoided

March 23, 2018
More than 135,500 cases of cancer a year in the UK could be prevented through lifestyle changes, according to new figures from a Cancer Research UK landmark study published today.

Metastatic lymph nodes can be the source of distant metastases in mouse models of cancer

March 22, 2018
A study by Massachusetts General Hospital (MGH) investigators finds that, in mouse models, cancer cells from metastatic lymph nodes can escape into the circulation by invading nodal blood vessels, leading to the development ...

Could a pap test spot more than just cervical cancer?

March 22, 2018
Pap tests have helped drive down rates of cervical cancer, and a new study suggests they also could be used to detect other gynecologic cancers early.

Researchers identify compound to prevent breast cancer cells from activating in brain

March 22, 2018
Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain.

Researchers examine role of fluid flow in ovarian cancer progression

March 22, 2018
New research from Virginia Tech is moving physicians closer to pinpointing a predictor of ovarian cancer, which could lead to earlier diagnosis of what is know as the "silent killer."

Gene-based test for urine detects, monitors bladder cancer

March 22, 2018
Researchers at The Johns Hopkins Kimmel Cancer Center have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.